Unveiling the Clinical Benefits of High-Volume Hemodiafiltration: Optimizing the Removal of Medium-Weight Uremic Toxins and Beyond

MLA

Cristian Pedreros-Rosales, et al. “Unveiling the Clinical Benefits of High-Volume Hemodiafiltration: Optimizing the Removal of Medium-Weight Uremic Toxins and Beyond.” Toxins, vol. 15, no. 9, Aug. 2023, p. 531. EBSCOhost, https://doi.org/10.3390/toxins15090531.

APA

Cristian Pedreros-Rosales, Aquiles Jara, Eduardo Lorca, Sergio Mezzano, Roberto Pecoits-Filho, & Patricia Herrera. (2023). Unveiling the Clinical Benefits of High-Volume Hemodiafiltration: Optimizing the Removal of Medium-Weight Uremic Toxins and Beyond. Toxins, 15(9), 531. https://doi.org/10.3390/toxins15090531

Chicago

Cristian Pedreros-Rosales, Aquiles Jara, Eduardo Lorca, Sergio Mezzano, Roberto Pecoits-Filho, and Patricia Herrera. 2023. “Unveiling the Clinical Benefits of High-Volume Hemodiafiltration: Optimizing the Removal of Medium-Weight Uremic Toxins and Beyond.” Toxins 15 (9): 531. doi:10.3390/toxins15090531.